|
| Status |
Public on Jan 25, 2024 |
| Title |
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors [KR158 RNA-TCR] |
| Organism |
Mus musculus |
| Experiment type |
Other
|
| Summary |
mRNA-based immunotherapeutics have garnered widespread interest for their potential to revolutionize cancer treatment. In this study, we have established a personalized and customizable mRNA-therapeutic approach that effectively targets a plurality of tumor antigens and demonstrated potent anti-tumor response in preclinical brain tumor models. Our platform uniquely addresses the challenge of tumor heterogeneity and low antigen burden, two key deficiencies in targeting classically immunotherapy-resistant CNS malignancies.
|
| |
|
| Overall design |
We created GBM tumor antigen-specific RNA and loaded it into dendritic cells for anti-tumor vaccine. We performed in vivo anti-tumor efficacy study with antigen loaded dendritic cells in combination with adoptive T cell therapy with relevant controls in the KR158 murine GBM model. Post therapy, we isolated the CD45+ve immune cells from the brain tumor microenvironment and performed TCR seq analysis from the RNA.
|
| |
|
| Contributor(s) |
Trivedi V, Yang C, Micthell D |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| BioProject |
PRJNA1054323 |
| |
| Submission date |
Dec 21, 2023 |
| Last update date |
Jan 26, 2024 |
| Contact name |
Duane Mitchell |
| E-mail(s) |
Duane.Mitchell@neurosurgery.ufl.edu
|
| Organization name |
University of Florida
|
| Street address |
1333 Center Drive, BSB B1-150
|
| City |
Gainesville |
| State/province |
Florida |
| ZIP/Postal code |
32610 |
| Country |
USA |
| |
|
| Platforms (1) |
|
| Samples (9)
|
|
Less...
More...